In addition to the “big four,” additional gene fusions have recently become known, such as those involving NRG1, SMARCA4, BRAF, FGFR1 and EGFR, further complicating the everyday molecular diagnostic practice of NSCLC. Here, BRAF is linked to non-small cell lung carcinoma.